-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Medline, Raises Price Target to $47

Benzinga·11/05/2026 21:49:17
Listen to the news
Citigroup analyst Joanne Wuensch maintains Medline (NASDAQ:MDLN) with a Buy and raises the price target from $45 to $47.